Investors considering a purchase of Krystal Biotech Inc (Symbol: KRYS ... Collecting that bid as the premium represents a 9.1% return against the $150 commitment, or a 16.3% annualized rate ...

The brainless jock stereotype is long gone, writes Ben Bryant. Long live the new gym bro, fuelled by a love of gains and a ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

The resurrection of the dire wolf by Colossal Biosciences marks a fascinating intersection of popular culture and cutting-edge science. Wh ...

Back in the day, entrepreneurs kept far away from government and policy, but today it's becoming common to go from business ...

Traditional silk, prized for its softness and lustrous appearance, has been a symbol of luxury for millennia ... weaving silk stronger than Kevlar, represent a remarkable leap in biomaterial ...

Merck KGaA plans to acquire SpringWorks Therapeutics (NASDAQ:SWTX) for approximately $3.9 billion, aiming to enhance its ...

Enbridge's natural gas utilities helped it during Q1, but they will not be as helpful over the next few quarters. Read why ...

Blue-chip high-yield stocks are popular for passive income and strong returns, but some now face growing risks. Learn more on ...

The quiet rise of K18—a premium haircare brand with a scientific soul—offers a textbook case of what modern consumers want, and what luxury brands must now deliver. Not louder claims. Not flashier ...

"We are delighted that VYJUVEK has been approved in Europe as a safe and effective therapy for the many patients across Europe suffering from DEB,” said Suma Krishnan, President of Research and ...

Amid the worst U.S.-China trade clash in modern history, Michelle Xia thinks she has something Chinese that Americans will want. It isn’t a $3 T-shirt or an electronic gadget. It is a cancer ...